XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Previously Reported
Retroactive application of recapitalization
Preferred Stock
Preferred Stock
Previously Reported
Common Stock
Common Stock
Series Y Preferred Units
Common Stock
Series X, Ordinary Units
Common Stock
Previously Reported
Common Stock
Previously Reported
Series Y Preferred Units
Common Stock
Previously Reported
Series X, Ordinary Units
Common Stock
Retroactive application of recapitalization
Common Stock
Retroactive application of recapitalization
Series X, Ordinary Units
Additional paid-in capital
Additional paid-in capital
Previously Reported
Additional paid-in capital
Retroactive application of recapitalization
Accumulated deficit
Accumulated deficit
Previously Reported
Preferred Stock, Beginning Balance (in shares) at Dec. 31, 2021       0 0                          
Common Stock, Beginning Balance (in shares) at Dec. 31, 2021           155,541,074 0 0 0 0 110,867,483 155,541,074 (110,867,483)          
Beginning balance at Dec. 31, 2021 $ 263,237 $ 263,237 $ 0 $ 0 $ 0 $ 16 $ 0 $ 0 $ 0 $ 0 $ 1 $ 16 $ (1) $ 269,116 $ 269,131 $ (15) $ (5,895) $ (5,895)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) 4,501                               4,501  
Interest on the promissory note to a member (741)                         (741)        
Related party unit-based compensation 349                         349        
Stock-based compensation 414                         414        
Exercise of stock options (in shares)           37,086                        
Exercise of stock options 119                         119        
Preferred Stock, Ending Balance (in shares) at Mar. 31, 2022       0                            
Common Stock, Ending Balance (in shares) at Mar. 31, 2022           155,578,160 0 0                    
Ending balance at Mar. 31, 2022 267,879     $ 0   $ 16 $ 0 $ 0           269,257     (1,394)  
Preferred Stock, Beginning Balance (in shares) at Dec. 31, 2021       0 0                          
Common Stock, Beginning Balance (in shares) at Dec. 31, 2021           155,541,074 0 0 0 0 110,867,483 155,541,074 (110,867,483)          
Beginning balance at Dec. 31, 2021 263,237 $ 263,237 $ 0 $ 0 $ 0 $ 16 $ 0 $ 0 $ 0 $ 0 $ 1 $ 16 $ (1) 269,116 $ 269,131 $ (15) (5,895) $ (5,895)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) 199                                  
Preferred Stock, Ending Balance (in shares) at Jun. 30, 2022       0                            
Common Stock, Ending Balance (in shares) at Jun. 30, 2022           155,848,980 0 0                    
Ending balance at Jun. 30, 2022 197,171     $ 0   $ 16 $ 0 $ 0           202,851     (5,696)  
Preferred Stock, Beginning Balance (in shares) at Mar. 31, 2022       0                            
Common Stock, Beginning Balance (in shares) at Mar. 31, 2022           155,578,160 0 0                    
Beginning balance at Mar. 31, 2022 267,879     $ 0   $ 16 $ 0 $ 0           269,257     (1,394)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) (4,302)                               (4,302)  
Member distributions (83,313)                         (83,313)        
Interest on the promissory note to a member (746)                         (746)        
Repayment of promissory note to a member 427                         427        
Payment of interest on promissory note to a member 3,362                         3,362        
Stock-based compensation 360                         360        
Exercise of stock options (in shares)           270,820                        
Exercise of stock options 906                         906        
Contribution from member - related party unit-based comp 12,598                         12,598        
Preferred Stock, Ending Balance (in shares) at Jun. 30, 2022       0                            
Common Stock, Ending Balance (in shares) at Jun. 30, 2022           155,848,980 0 0                    
Ending balance at Jun. 30, 2022 $ 197,171     $ 0   $ 16 $ 0 $ 0           202,851     (5,696)  
Preferred Stock, Beginning Balance (in shares) at Dec. 31, 2022 0     0                            
Common Stock, Beginning Balance (in shares) at Dec. 31, 2022 173,524,360         173,524,360                        
Beginning balance at Dec. 31, 2022 $ 4,052     $ 0   $ 17               9,078     (5,043)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) (32,899)                               (32,899)  
Interest on the promissory note to a member (282)                         (282)        
Repayment of promissory note to a member 18,833                         18,833        
Payment of interest on promissory note to a member 520                         520        
Stock-based compensation 3,126                         3,126        
Vested restricted stock units (in shares)           21,875                        
Exercise of stock options (in shares)           296,477                        
Exercise of stock options 1,010                         1,010        
Preferred Stock, Ending Balance (in shares) at Mar. 31, 2023       0                            
Common Stock, Ending Balance (in shares) at Mar. 31, 2023           173,842,712                        
Ending balance at Mar. 31, 2023 $ (5,640)     $ 0   $ 17               32,285     (37,942)  
Preferred Stock, Beginning Balance (in shares) at Dec. 31, 2022 0     0                            
Common Stock, Beginning Balance (in shares) at Dec. 31, 2022 173,524,360         173,524,360                        
Beginning balance at Dec. 31, 2022 $ 4,052     $ 0   $ 17               9,078     (5,043)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) $ (10,568)                                  
Preferred Stock, Ending Balance (in shares) at Jun. 30, 2023 0     0                            
Common Stock, Ending Balance (in shares) at Jun. 30, 2023 173,524,360         174,053,659                        
Ending balance at Jun. 30, 2023 $ 20,797     $ 0   $ 17               36,391     (15,611)  
Preferred Stock, Beginning Balance (in shares) at Mar. 31, 2023       0                            
Common Stock, Beginning Balance (in shares) at Mar. 31, 2023           173,842,712                        
Beginning balance at Mar. 31, 2023 (5,640)     $ 0   $ 17               32,285     (37,942)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) 22,331                               22,331  
Stock-based compensation 3,432                         3,432        
Vested restricted stock units (in shares)           21,875                        
Exercise of stock options (in shares)           189,072                        
Exercise of stock options $ 674                         674        
Preferred Stock, Ending Balance (in shares) at Jun. 30, 2023 0     0                            
Common Stock, Ending Balance (in shares) at Jun. 30, 2023 173,524,360         174,053,659                        
Ending balance at Jun. 30, 2023 $ 20,797     $ 0   $ 17               $ 36,391     $ (15,611)